ADYEY vs. NVO

Last updated Jun 4, 2026

ADYEY (Adyen NV) and NVO (Novo Nordisk A/S) are both stocks. ADYEY operates in Software - Infrastructure (Technology), while NVO operates in Biotechnology (Healthcare). Over the past 5 years, ADYEY returned -15.42%/yr vs 2.89%/yr for NVO. At a 0.28 correlation, their price movements are largely independent.

Performance

ADYEY vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Adyen NV (ADYEY) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ADYEY achieves a -38.76% return, which is significantly lower than NVO's -14.57% return.

ADYEY

• 1D: -5.23%
• 1M: -13.37%
• YTD: -38.76%
• 6M: -38.45%
• 1Y: -48.50%
• 3Y*: -16.80%
• 5Y*: -15.42%
• 10Y*: —

NVO

• 1D: -2.14%
• 1M: -5.38%
• YTD: -14.57%
• 6M: -8.62%
• 1Y: -38.01%
• 3Y*: -16.72%
• 5Y*: 2.89%
• 10Y*: 6.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ADYEY vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
ADYEY Adyen NV	-38.76%	8.94%	13.82%	-6.67%	-47.57%	13.45%	181.82%	30.36%
NVO Novo Nordisk A/S	-14.57%	-39.22%	-15.93%	54.84%	22.66%	63.52%	23.33%	14.86%

Correlation

The correlation between ADYEY and NVO is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.28
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (All Time) Calculated using the full available price history since Oct 4, 2019	0.28

Fundamentals

Market Cap ADYEY : $30.92B NVO : $186.85B
EPS ADYEY : $0.63 NVO : $27.42
PE Ratio ADYEY : 15.58 NVO : 1.53
PEG Ratio ADYEY : 0.73 NVO : 0.07
PS Ratio ADYEY : 6.52 NVO : 0.57
PB Ratio ADYEY : 5.85 NVO : 0.92
Total Revenue (TTM) ADYEY : $4.74B NVO : $327.80B
Gross Profit (TTM) ADYEY : $3.83B NVO : $268.30B
EBITDA (TTM) ADYEY : $2.71B NVO : $181.54B

Return for Risk

ADYEY vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADYEY

ADYEY Risk / Return Rank: 3
ADYEY Sharpe Ratio Rank: 2
ADYEY Sortino Ratio Rank: 3
ADYEY Omega Ratio Rank: 3
ADYEY Calmar Ratio Rank: 3
ADYEY Martin Ratio Rank: 3

NVO

NVO Risk / Return Rank: 14
NVO Sharpe Ratio Rank: 10
NVO Sortino Ratio Rank: 13
NVO Omega Ratio Rank: 12
NVO Calmar Ratio Rank: 15
NVO Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ADYEY vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Adyen NV (ADYEY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ADYEY	NVO	Difference
Sharpe ratio Return per unit of total volatility	-1.22	-0.74	-0.49
Sortino ratio Return per unit of downside risk	-1.79	-0.83	-0.96
Omega ratio Gain probability vs. loss probability	0.76	0.88	-0.12
Calmar ratio Return relative to maximum drawdown	-0.95	-0.69	-0.26
Martin ratio Return relative to average drawdown	-1.67	-1.03	-0.64
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ADYEY vs. NVO - Sharpe Ratio Comparison

The current ADYEY Sharpe Ratio is -1.22, which is lower than the NVO Sharpe Ratio of -0.74. The chart below compares the historical Sharpe Ratios of ADYEY and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ADYEY	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.22	-0.74	-0.49
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.30	0.08	-0.37
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.19	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.13	0.47	-0.34

Drawdowns

ADYEY vs. NVO - Drawdown Comparison

The maximum ADYEY drawdown since its inception was -79.84%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for ADYEY and NVO.

Drawdown Indicators

	ADYEY	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-79.84%	-74.70%	-5.14%
Max Drawdown (1Y) Largest decline over 1 year	-51.00%	-55.03%	+4.03%
Max Drawdown (3Y) Largest decline over 3 years	-64.34%	-74.70%	+10.36%
Max Drawdown (5Y) Largest decline over 5 years	-79.84%	-74.70%	-5.14%
Max Drawdown (10Y) Largest decline over 10 years	—	-74.70%	—
Current Drawdown Current decline from peak	-70.13%	-69.48%	-0.65%
Average Drawdown Average peak-to-trough decline	-38.43%	-17.76%	-20.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	29.07%	36.88%	-7.81%

Volatility

ADYEY vs. NVO - Volatility Comparison

Adyen NV (ADYEY) has a higher volatility of 10.63% compared to Novo Nordisk A/S (NVO) at 7.84%. This indicates that ADYEY's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ADYEY	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.63%	7.84%	+2.79%
Volatility (6M) Calculated over the trailing 6-month period	34.17%	37.83%	-3.66%
Volatility (1Y) Calculated over the trailing 1-year period	39.75%	51.76%	-12.01%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	52.24%	38.21%	+14.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	50.55%	32.49%	+18.06%

Dividends

ADYEY vs. NVO - Dividend Comparison

ADYEY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.29%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ADYEY Adyen NV	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	4.29%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Financials

ADYEY vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Adyen NV and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ADYEY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Adyen NV reported a gross profit of 1.11B and revenue of 1.41B. Therefore, the gross margin over that period was 78.8%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

ADYEY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Adyen NV reported an operating income of 622.48M and revenue of 1.41B, resulting in an operating margin of 44.1%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

ADYEY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Adyen NV reported a net income of 577.26M and revenue of 1.41B, resulting in a net margin of 40.9%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

Frequently Asked Questions

Can I hold both ADYEY and NVO in my portfolio?

ADYEY and NVO have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ADYEY or NVO?

ADYEY has higher volatility (10.63%) compared to NVO (7.84%). In terms of maximum drawdown, ADYEY dropped -79.84% vs NVO's -74.70%.

Which has better risk-adjusted returns?

NVO currently has the higher Sharpe Ratio (-0.74 vs -1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.